RESUMO
Our study showed a statistically significant incidence of pulmonary edema in mice receiving amiodarone and 100% oxygen. This finding, together with a variety of clinical reports, indicates that in patients receiving amiodarone therapy, FiO2 should be maintained at the lowest possible level, consistent with adequate oxygenation.
Assuntos
Amiodarona/efeitos adversos , Antiarrítmicos/efeitos adversos , Pulmão/metabolismo , Oxigênio/metabolismo , Edema Pulmonar/induzido quimicamente , Vasodilatadores/efeitos adversos , Animais , Masculino , Camundongos , Camundongos Endogâmicos , Edema Pulmonar/metabolismo , RespiraçãoAssuntos
Ecocardiografia , Transplante de Coração/fisiologia , Função Ventricular Direita/fisiologia , Cardiomiopatia Dilatada/cirurgia , Dilatação Patológica/diagnóstico por imagem , Ecocardiografia/métodos , Embolia Aérea/diagnóstico por imagem , Esôfago , Cardiopatias/diagnóstico por imagem , Ventrículos do Coração/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Using human adipose stromal cells in monolayer culture as a model system for study of the regulation of aromatase activity, as well as polyclonal antibodies raised in this laboratory against aromatase cytochrome P-450 (cytochrome P-450AROM), it was found that the rate of synthesis of cytochrome P-450AROM was stimulated by dibutyryl cyclic AMP. This stimulation was attenuated by epidermal growth factor and was potentiated by phorbol esters. These changes in cytochrome P-450AROM synthesis were associated with comparable changes in the levels of translatable cytochrome P-450AROM mRNA, as well as with changes in the activity of aromatase of these cells. By contrast, there was little change in the synthesis of the reductase component of the aromatase enzyme complex in response to these factors. The increase in mRNA was blocked by cycloheximide, indicative of a requirement for protein synthesis in mediating this inductive response. It is concluded that aromatase activity is regulated primarily by changes in the level of mRNA encoding cytochrome P-450AROM, and that such changes are likely a reflection of changes in the rate of transcription of the gene encoding this enzyme. Increases in the levels of cytochrome P-450AROM mRNA are apparently mediated by a regulatory protein(s), similar to that found for other steroidogenic forms of cytochrome P-450.